Year |
Citation |
Score |
2020 |
Duskey JT, Ottonelli I, Ros FD, Vilella A, Zoli M, Kovachka S, Spyrakis F, Vandelli MA, Tosi G, Ruozi B. Novel peptide-conjugated nanomedicines for brain targeting: in vivo evidences. Nanomedicine : Nanotechnology, Biology, and Medicine. 102226. PMID 32479916 DOI: 10.1016/J.Nano.2020.102226 |
0.432 |
|
2020 |
Hoyos-Ceballos GP, Ruozi B, Ottonelli I, Da Ros F, Vandelli MA, Forni F, Daini E, Vilella A, Zoli M, Tosi G, Duskey JT, López-Osorio BL. PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study. Pharmaceutics. 12. PMID 31963430 DOI: 10.3390/Pharmaceutics12010072 |
0.351 |
|
2019 |
Pederzoli F, Ruozi B, Duskey J, Hagmeyer S, Sauer AK, Grabrucker S, Coelho R, Oddone N, Ottonelli I, Daini E, Zoli M, Vandelli MA, Tosi G, Grabrucker AM. Nanomedicine Against Aβ Aggregation by β-Sheet Breaker Peptide Delivery: In Vitro Evidence. Pharmaceutics. 11. PMID 31683907 DOI: 10.3390/Pharmaceutics11110572 |
0.437 |
|
2019 |
Rigon L, Salvalaio M, Pederzoli F, Legnini E, Duskey JT, D'Avanzo F, De Filippis C, Ruozi B, Marin O, Vandelli MA, Ottonelli I, Scarpa M, Tosi G, Tomanin R. Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles. International Journal of Molecular Sciences. 20. PMID 31022913 DOI: 10.3390/Ijms20082014 |
0.31 |
|
2016 |
Nussbaumer MG, Duskey JT, Rother M, Renggli K, Chami M, Bruns N. Chaperonin-Dendrimer Conjugates for siRNA Delivery. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 3: 1600046. PMID 27840795 DOI: 10.1002/Advs.201600046 |
0.325 |
|
2016 |
Sigg SJ, Postupalenko V, Duskey JT, Palivan CG, Meier W. Stimuli-Responsive Codelivery of Oligonucleotides and Drugs by Self-Assembled Peptide Nanoparticles. Biomacromolecules. PMID 26871486 DOI: 10.1021/Acs.Biomac.5B01614 |
0.486 |
|
2016 |
Dinu IA, Duskey JT, Car A, Palivan CG, Meier W. Engineered non-toxic cationic nanocarriers with photo-triggered slow-release properties Polymer Chemistry. 7: 3451-3464. DOI: 10.1039/C6Py00343E |
0.355 |
|
2015 |
Baumhover NJ, Duskey JT, Khargharia S, White CW, Crowley ST, Allen RJ, Rice KG. Structure-Activity Relationship of PEGylated Polylysine Peptides as Scavenger Receptor Inhibitors for Non-Viral Gene Delivery. Molecular Pharmaceutics. PMID 26485572 DOI: 10.1021/Acs.Molpharmaceut.5B00513 |
0.759 |
|
2015 |
Li J, Crowley ST, Duskey J, Khargharia S, Wu M, Rice KG. Miniaturization of gene transfection assays in 384- and 1536-well microplates. Analytical Biochemistry. 470: 14-21. PMID 25448623 DOI: 10.1016/J.Ab.2014.10.001 |
0.602 |
|
2015 |
Allen R, Baumhover N, Duskey J, Rice K. 271. Improved Gene Transfer with a New Class of PEG-Peptide Scavenger Receptor Inhibitors Molecular Therapy. 23: S108. DOI: 10.1016/S1525-0016(16)33880-1 |
0.766 |
|
2014 |
Khargharia S, Baumhover NJ, Crowley ST, Duskey J, Rice KG. The uptake mechanism of PEGylated DNA polyplexes by the liver influences gene expression. Gene Therapy. 21: 1021-8. PMID 25253445 DOI: 10.1038/Gt.2014.81 |
0.726 |
|
2014 |
Duskey JT, Rice KG. Nanoparticle ligand presentation for targeting solid tumors. Aaps Pharmscitech. 15: 1345-54. PMID 24927668 DOI: 10.1208/S12249-014-0143-6 |
0.531 |
|
2011 |
Fernandez CA, Baumhover NJ, Duskey JT, Khargharia S, Kizzire K, Ericson MD, Rice KG. Metabolically stabilized long-circulating PEGylated polyacridine peptide polyplexes mediate hydrodynamically stimulated gene expression in liver. Gene Therapy. 18: 23-37. PMID 20720577 DOI: 10.1038/Gt.2010.117 |
0.584 |
|
Show low-probability matches. |